Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies, 68065 [E9-30362]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 244 / Tuesday, December 22, 2009 / Notices
FCC Form 2000 A through F will remain
unchanged.
The FCC Form 475–B Consumer
Complaint Form asks complainants to
provide their contact information,
including address, telephone number,
and e–mail address, and to describe
their complaint(s) and issue(s)
concerning the practices of
telecommunications entities, which
they believe may have aired obscene,
profane, and/or indecent programming.
The FCC Form 475–B will remain
unchanged.
The FCC Form 1088 Consumer
Complaint Form asks complainants to
provide their contact information,
including address, telephone number,
and e–mail address, and to describe
their complaints and issues regarding
‘‘Do Not Call’’ and ‘‘Junk Fax’’ as well
as other related consumer protection
issues such as prerecorded messages,
automatic telephone dialing systems,
and unsolicited commercial e–mail
messages to wireless
telecommunications devices. The FCC
Form 1088 A through H will remain
unchanged.
The FCC Form 501 Consumer
Complaint Form asks complainants to
provide their contact information,
including address, telephone number,
and e–mail address, and to describe
their complaints and issues regarding
alleged slamming violations. The FCC
Form 501 will remain unchanged.
All of the FCC Complaint Forms are
being consolidated into this collection
(and being deleted from OMB Control
Number 3060–1088 and discontinued in
OMB Control Number 3060–0968) in
order to allow the Commission to better
manage all forms used to collect
informal consumer complaints.
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary, Office of
Managing Director.
[FR Doc. E9–30373 Filed 12–21–09 8:45 am]
BILLING CODE 6712–01–S
FEDERAL RESERVE SYSTEM
srobinson on DSKHWCL6B1PROD with NOTICES
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
VerDate Nov<24>2008
19:28 Dec 21, 2009
Jkt 220001
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than January
6, 2010.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Clary Anthony Family Irrevocable
Trust No. 101; Lynda June Anthony,
both of Shreveport, Louisiana; Luther
Clary Anthony, Jr., Atlanta, Texas, Co
Trustees; Lynda June Anthony,
Shreveport, Louisiana; Luther Clary
Anthony, Jr., Atlanta, Texas; and Luther
Clary Anthony Sr., Springhill,
Louisiana, individually, to retain voting
shares of and acquire additional shares
of Citizens Bankshares of Springhill,
Inc., and thereby indirectly retain and
acquire additional voting shares of
Citizens Bank & Trust Company, both of
Springhill, Louisiana.
Board of Governors of the Federal Reserve
System, December 17, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9–30362 Filed 12–21–09; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Investigator
Registration and Financial Disclosure
for Investigational Trials in Cancer
Treatment (NCI)
SUMMARY: In compliance with the
requirement of Section 3507(a)(1)(D) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute, the National
Cancer Institute (NIH) has submitted to
the Office of Management and Budget
(OMB) a request for review and
approval of the information collected
below. This proposed information
collection was previously published in
the Federal Register on June 10, 2009
(74 FR 27552), and allowed 60-days for
public comment. One public comment
was received regarding pharmaceutical
testing. The submitter responded to the
e-mail. The purpose of this notice is to
allow an additional 30 days for public
comment. The National Institutes of
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
68065
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a valid OMB
control number.
Proposed Collection: Title:
Investigator Registration and Financial
Disclosure for Investigational Trials in
Cancer Treatment (NCI). Type of
Information Collection Request: Existing
Collection in Use without an OMB
Number. Need and Use of Information
Collection: Food and Drug
Administration (FDA) regulations
require requires sponsors to obtain
information from the investigator before
permitting the investigator to begin
participation in investigational studies.
The National Cancer Institute, (NCI) as
a sponsor of investigational drug trials,
has the responsibility to assure the FDA
that investigators in its clinical trials
program are qualified by training and
experience as appropriate experts to
investigate the drug. In order to fulfill
these requirements, a standard
Statement of Investigator (FDA Form
1572 modified), Supplemental
Investigator Data Form, Financial
Disclosure Form and Curriculum vitae
(CV) are required. The NCI will accept
the investigator’s CV in any format. All
investigators maintain a CV as part of
their academic and professional
practice. The data obtained from these
forms allows the NCI to evaluate the
qualifications of the investigator,
identify appropriate personnel to
receive shipment of investigational
agent, ensure supplies are not diverted
for inappropriate protocol or patient use
and identify financial conflicts of
interest. Comparisons are done with the
intention of ensuring protocol, patient
safety and drug compliance for patient
and drug compliance for patient safety
and protections. Frequency of Response:
Annually. Affected Public: Public
sector, businesses or other for-profit that
will include Federal agencies or
employees, non-profit institutions and a
very small number of private practice
physicians. Type of Respondents:
Investigators. The annual reporting
burden is limited to those physicians
who choose to participate in NCI
sponsored investigational trials to
identify new medicinal agents to treat
and relieve those patients suffering from
cancer. The annualized respondents’
burden for record keeping is estimated
to require 8,564 hours (see table below).
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 74, Number 244 (Tuesday, December 22, 2009)]
[Notices]
[Page 68065]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30362]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices; Acquisition of Shares of Bank or
Bank Holding Companies
The notificants listed below have applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company.
The factors that are considered in acting on the notices are set forth
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
The notices are available for immediate inspection at the Federal
Reserve Bank indicated. The notices also will be available for
inspection at the office of the Board of Governors. Interested persons
may express their views in writing to the Reserve Bank indicated for
that notice or to the offices of the Board of Governors. Comments must
be received not later than January 6, 2010.
A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President)
2200 North Pearl Street, Dallas, Texas 75201-2272:
1. Clary Anthony Family Irrevocable Trust No. 101; Lynda June
Anthony, both of Shreveport, Louisiana; Luther Clary Anthony, Jr.,
Atlanta, Texas, Co Trustees; Lynda June Anthony, Shreveport, Louisiana;
Luther Clary Anthony, Jr., Atlanta, Texas; and Luther Clary Anthony
Sr., Springhill, Louisiana, individually, to retain voting shares of
and acquire additional shares of Citizens Bankshares of Springhill,
Inc., and thereby indirectly retain and acquire additional voting
shares of Citizens Bank & Trust Company, both of Springhill, Louisiana.
Board of Governors of the Federal Reserve System, December 17,
2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9-30362 Filed 12-21-09; 8:45 am]
BILLING CODE 6210-01-S
